EDUCATION:
1983-A.A. Saddleback Community College, Nursing Program
Mission Viejo, California
1992-B.S.N California State University Dominguez Hills, Statewide Nursing Program
1995-M.N. University of California Los Angeles, School of Nursing, Los Angeles California, Pediatric Nurse Practitioner Specialty

LICENSES:
Nurse Practitioner-California 1995 License #7867
Registered Nurse-California 1984 License # E369891
Certified with the Nursing Child Assessment Satellite Training Program-California 1984
Nurse Practitioner Furnishing License 1996 License #NPF 7867

CERTIFICATIONS:
Certified Pediatric Nurse Practitioner, 1995

CLINICAL EXPERIENCE:
1. Kaiser Permanente, Huntington Beach, California, 1995
2. University of California, Irvine Medical Center, Orange, California, 1994-95
3. Pediatric and Adolescent Medicine Group, Tustin, California, 1994-95
4. Teacher's Assistant for a UCLA Bachelor of Science in Nursing program course in Nursing Theory, 1994
5. Tutor in Human Physiology at Saddleback College, 1981-84
6. Volunteer La Leche League Leader, 1971-74

HONORS AND AWARDS:
1995 Inducted into Sigma Theta Tau, National Nursing Society for recognition of scholarly achievements
1992 Award of excellence in the role of patient education at UCI Medical Center
1992 Graduated Magna Cum Laude from California State University
1991 & 1992 Awarded a scholarship from the Associates for the Advancement of Nursing Science and Research
1983 Valedictorian of graduating class, Saddleback College

PRESENTATIONS:

1. Managing Your Child's Asthma. Presented as part of the Asthma Outreach Program, Saddleback Valley Unified School District, Mission Viejo, California, February, March, and April, 1998.
2. The Respiratory System. Presented as part of course requirements in Medical Terminology at Saddleback College, Mission Viejo, California, 1997 and 1998.
3. Families Living With Asthma. California Society of Allergy, Asthma, and Clinical Immunology LaCosta, California, August, 1997.

RESEARCH ACTIVITIES: Associate Investigator

A 12-Week Comparison of Daily Doses of Drug 100 mcg and 200 mcg of Drug, an inhaler, Versus Placebo in the Autohaler Device in Pediatric Patients with Symptomatic Asthma

A Multicenter, Double Masked, Randomized, Parallel, Three-Month Study (With an Extention to One Year) of the Safety, Efficacy, and Acceptability Of 0.15% and 0.2% Eye Drops Compared with 0.2% Eye Drops in Subjects with Glaucoma or Ocular Hypertention

A Multicenter, Double-Masked, Randomized, Parallel Study of the Safety and Efficacy of Twice-Daily Dosed eye drop Combination Compared with Twice-Daily Dosed or Three-Times-Daily Dosed eye drops for Three Months (Plus 9-Month, Masked Extension) in Patients with Glaucoma or Ocular Hypertension

Inhaled Drug Treatment As Regular Therapy in Early Asthma

A Multicenter, Double-Blind,Randomized, Placebo-Controlled, Parallel Study to Assess the Safety and Tolerability of a Drug Twice a Day During Treatment of Children 2 Through 5 Years of Age with Allergic Rhinitis.

Prospective, Randomized, Double-Blind, Multi-Center Comparison of the Safety and Efficacy of an Antibiotic for Five Days Versus a Second Antibiotic for Seven Days in the Treatment of Patients with Acute Exacerbation of Chronic Bronchitis

An Open Label,Multi-Dose, Multicenter Study to Evaluate the Safety of an Inhaler and Reliability of the "To-Be-Marketed" Dry Powder Inhaler in Patients With Asthma

An Open Label Study to Evaluate the Safety of Topically Applied Ointment for the Treatment of Atop Dermatitis

A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled 12-Week Study of Drug BID and Drug BID Delivered via CFC MDI and a Valved Holding Chamber with Facemask in Subjects with Asthma Age 24 Months to 47 Months

A Randomized, Double-Blind, Parallel Group Trial Assessing the Efficacy and Safety of Drug (250mcg QD) and Placebo in Subjects Greater than 12 years of Age with Chronic Asthma

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multi-Center Study to Investigate the Efficacy and Safety of Inhaled Medication 10 Mg Administered Twice Daily for Five Days in the Treatment of Influenza in Patients 12 Years Or Over Diagnosed with Asthma Or Chronic Obstructive Pulmonary Disease

Efficacy and Safety of an Antihistamine in Subjects with Seasonal Allergic Rhinitis and Concurrent Asthma

Efficacy and Safety of an antihistamine in Patients with Perennial Allergic Rhinitis

Efficacy and Safety of an Antihistamine in the Treatment of Chronic Idiopathic Urticaria (CIU)

An Efficacy, Safety and Tolerability Study of Daily Dosing With an Nebulized Solution in Pediatric Subjects with Asthma

A Twelve-Month Safety Study of 30mg Antihistamine, QD in Normal Healthy Subjects

A Safety, Efficacy and Tolerability Study of Multiple Once-Daily Doses of a Drug Inhalation Solution in Subjects with Asthma

A Phase III, 7 Month Double-Blind, Randomized, Parallel-group, Placebo-Controlled, Multicenter Trial with a 5-Month Blind Extension Period to Assess Efficacy, Safety, Tolerability , Steroid-Reduction, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Drug in Adolescents and Adults with Moderate to Severe Allergic Asthma Requiring Daily Treatment of Inhaled Corticosteroids

A randomized, Double-blind, parallel group, placebo controlled multicenter study of the efficacy and safety of Drug vs Drug vs placebo in the treatment of subjects twelve years and older with seasonal allergic rhinitis.

An Observational Study to Assess Prevalence, Natural History, and Burden of Illness of Irritable Bowel Syndrome (IBS) in Clinical Practice and to Evaluate the Impact of Drug Treatment on Natural History and Burden of Illness in a Cohort of Females Whose Predominant Bowel Symptom is Diarrhea